Class 2 Medicines Recall: Mollipaxin 100mg capsules (one batch)

Winthrop Pharmaceuticals UK Limited (trading as Zentiva) is conducting a precautionary recall of a single batch of Mollipaxin 100 mg capsules due to a potential issue with the metal detector during manufacture of the batch (EL(18) A/01).

Update: First published.

For further information on this published alert click here.

 

Recommended

RPS condemns the cuts – again

The Royal Pharmaceutical Society in England has reaffirmed its opposition to the community pharmacy funding cuts

Gearing up for the flu vaccination 2018-19

Information and promotional resources to support the 2018-19 flu vaccination programme are becoming available, including...


By using this website, you accept Pharmacy Magazine Terms of Use, Privacy Policy and Cookie Policy. Click accept to hide box. By continuing browsing you have confirmed your acceptance.